| Q44815007 | An improved mouse model for endometriosis allows noninvasive assessment of lesion implantation and development. |
| Q36272877 | Beneficial regulation of type I collagen and matrixmetalloproteinase-1 expression by estrogen, progesterone, and its combination in skin fibroblasts |
| Q39183896 | Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models |
| Q34570740 | Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis |
| Q33874669 | Dioxin and endometrial progesterone resistance |
| Q34010947 | Dioxin may promote inflammation-related development of endometriosis |
| Q48845686 | Endometriosis is sustained by tumour necrosis factor-alpha |
| Q33862747 | Experimental endometriosis in immunocompromised mice after adoptive transfer of human leukocytes |
| Q47908125 | Expression of Smad2 and Smad4, transforming growth factor-beta signal transducers in rat endometrium during the estrous cycle, pre-, and peri-implantation |
| Q37349676 | Extracellular matrix metalloproteinase inducer expression in the baboon endometrium: menstrual cycle and endometriosis |
| Q53163112 | Fenretinide: A Potential Treatment for Endometriosis. |
| Q35102841 | Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding |
| Q35186353 | Leiomyoma-derived transforming growth factor-β impairs bone morphogenetic protein-2-mediated endometrial receptivity |
| Q92932851 | Matrix metallopeptidase expression and modulation by transforming growth factor-β1 in equine endometrosis |
| Q55223594 | Matrix remodeling and endometriosis. |
| Q53239739 | Medical Management of Endometriosis. |
| Q24301427 | Opposite regulation of transforming growth factors-beta2 and -beta3 expression in the human endometrium |
| Q73279940 | Pathogenesis of endometriosis |
| Q24801366 | Potential involvement of the immune system in the development of endometriosis |
| Q28477124 | Puerarin suppresses invasion and vascularization of endometriosis tissue stimulated by 17β-estradiol |
| Q44848772 | Quantitative assessment of human endometriotic tissue maintenance and regression in a noninvasive mouse model of endometriosis |
| Q54962618 | Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets. |
| Q91632097 | The Effect of Imbalanced Progesterone Receptor-A/-B Ratio on Gelatinase Expressions in Endometriosis |
| Q90683993 | The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) |
| Q38349281 | The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-beta |
| Q37373670 | The role of transforming growth factor beta in cervical remodeling within the rat cervix |
| Q33643238 | Transforming growth factor-beta1 attenuates expression of both the progesterone receptor and Dickkopf in differentiated human endometrial stromal cells |